As of Jul 21
| +0.15 / +0.31%|
The 2 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 62.50, with a high estimate of 69.00 and a low estimate of 56.00. The median estimate represents a +28.76% increase from the last price of 48.54.
The current consensus among 2 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.